⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASND News
Ascendis Pharma A/S American Depositary Shares
ATI Engage® Series Honored with Gold Stevie® Award for Technology Breakthrough of the Year in Educational Technology
globenewswire.com
ASND
Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial
globenewswire.com
ASND
Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
globenewswire.com
ASND
Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026
globenewswire.com
ASND
V2 Communications to Host Webinar on CEO Visibility as a Business Imperative
globenewswire.com
RKT
ASND
Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
globenewswire.com
ASND
5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism
globenewswire.com
ASND
ATI Engage® Honored for Advancing Digital Learning in Nursing Education
globenewswire.com
ASND
Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026
globenewswire.com
ASND
International Bridge and Asendia USA Collaborate to Expand Non-Continental U.S. Delivery Capabilities
prnewswire.com
ASND